Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAL 60plus: Mitoxantrone vs Daunorubicin in Elderly AML
NCT00180167Phase 4Completed
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2005
- Primary completion
- Jul 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of mitoxantrone in acute myeloid leukemia (AML), sponsored by Technische Universität Dresden. Started Jan 2005; status: completed.
02
Drugs
mitoxantrone
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00180167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180167.